8
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Regulation of alveolar epithelial cell apoptosis and pulmonary fibrosis by coordinate expression of components of the fibrinolytic system.

      American Journal of Physiology - Lung Cellular and Molecular Physiology

      metabolism, genetics, Urokinase-Type Plasminogen Activator, Tumor Suppressor Protein p53, physiopathology, drug effects, Respiratory Mucosa, Receptors, Urokinase Plasminogen Activator, prevention & control, pathology, chemically induced, Pulmonary Fibrosis, Pulmonary Alveoli, Poly(ADP-ribose) Polymerases, Plasminogen Activator Inhibitor 1, therapeutic use, pharmacology, Peptide Fragments, Mice, Transgenic, Mice, Inbred C57BL, Mice, Lung, Humans, Gene Expression, Cytoprotection, Collagen, Cells, Cultured, Caveolin 1, Bleomycin, Apoptosis, Animals, Acute Lung Injury

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Alveolar type II (ATII) cell apoptosis and depressed fibrinolysis that promotes alveolar fibrin deposition are associated with acute lung injury (ALI) and the development of pulmonary fibrosis (PF). We therefore sought to determine whether p53-mediated inhibition of urokinase-type plasminogen activator (uPA) and induction of plasminogen activator inhibitor-1 (PAI-1) contribute to ATII cell apoptosis that precedes the development of PF. We also sought to determine whether caveolin-1 scaffolding domain peptide (CSP) reverses these changes to protect against ALI and PF. Tissues as well as isolated ATII cells from the lungs of wild-type (WT) mice with BLM injury show increased apoptosis, p53, and PAI-1, and reciprocal suppression of uPA and uPA receptor (uPAR) protein expression. Treatment of WT mice with CSP reverses these effects and protects ATII cells against bleomycin (BLM)-induced apoptosis whereas CSP fails to attenuate ATII cell apoptosis or decrease p53 or PAI-1 in uPA-deficient mice. These mice demonstrate more severe PF. Thus p53 is increased and inhibits expression of uPA and uPAR while increasing PAI-1, changes that promote ATII cell apoptosis in mice with BLM-induced ALI. We show that CSP, an intervention targeting this pathway, protects the lung epithelium from apoptosis and prevents PF in BLM-induced lung injury via uPA-mediated inhibition of p53 and PAI-1.

          Related collections

          Author and article information

          Journal
          10.1152/ajplung.00099.2011
          22140072
          3311514

          Comments

          Comment on this article